" However, clinical trials of albumin have shown conflicting results." https://t.co/rBW7AVgU9z https://t.co/yhepuPqSGs https://t.co/6qZBja0Rom
Open Access UCL Research: Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis https://t.co/o09GMtNHhb
RT @NIHRCRSU: Some of the Network meta-analyses supported by CRSU in 2019- interventions in Crohn’s disease; https://t.co/9UpdS9mZKF, and t…
RT @NIHRCRSU: Some of the Network meta-analyses supported by CRSU in 2019- interventions in Crohn’s disease; https://t.co/9UpdS9mZKF, and t…
Not forgetting @NJCooperUke and @NeilSHawkins @HEHTAGlasgow
Some of the Network meta-analyses supported by CRSU in 2019- interventions in Crohn’s disease; https://t.co/9UpdS9mZKF, and treatments for bacterial peritonitis; https://t.co/r8X8tdXKVj & hepato-renal syndrome; https://t.co/rP3ngP6gyI. @CochraneUK @ajs
Looking back on a busy year for #NIHRCRSU and some of the 2019 Cochrane Systematic Reviews that CRSU members have co-authored; Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis https://t.co/jGeDOYdAz6
Traitement du syndrome hépatorénal https://t.co/ENdz3Kch5Y
RT @BlameOxytocin: Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. https://t.co/Y…
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. https://t.co/YmVGGBQx1O